These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 3001519

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Intranasal interferon-alpha 2 for prevention of natural rhinovirus colds.
    Farr BM, Gwaltney JM, Adams KF, Hayden FG.
    Antimicrob Agents Chemother; 1984 Jul; 26(1):31-4. PubMed ID: 6089652
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Intranasal interferon (rIFN-alpha A, Ro 22-8181) for contact prophylaxis against common cold: a randomized, double-blind and placebo-controlled field study.
    Herzog C, Berger R, Fernex M, Friesecke K, Havas L, Just M, Dubach UC.
    Antiviral Res; 1986 May; 6(3):171-6. PubMed ID: 3524441
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Ineffectiveness of postexposure prophylaxis of rhinovirus infection with low-dose intranasal alpha 2b interferon in families.
    Monto AS, Schwartz SA, Albrecht JK.
    Antimicrob Agents Chemother; 1989 Mar; 33(3):387-90. PubMed ID: 2543280
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Intranasal interferon-alpha 2 treatment of experimental rhinoviral colds.
    Hayden FG, Gwaltney JM.
    J Infect Dis; 1984 Aug; 150(2):174-80. PubMed ID: 6381610
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prevention of experimental coronavirus colds with intranasal alpha-2b interferon.
    Turner RB, Felton A, Kosak K, Kelsey DK, Meschievitz CK.
    J Infect Dis; 1986 Sep; 154(3):443-7. PubMed ID: 3016111
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Ineffectiveness of intranasal zinc gluconate for prevention of experimental rhinovirus colds.
    Turner RB.
    Clin Infect Dis; 2001 Dec 01; 33(11):1865-70. PubMed ID: 11692298
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers.
    Hayden FG, Turner RB, Gwaltney JM, Chi-Burris K, Gersten M, Hsyu P, Patick AK, Smith GJ, Zalman LS.
    Antimicrob Agents Chemother; 2003 Dec 01; 47(12):3907-16. PubMed ID: 14638501
    [Abstract] [Full Text] [Related]

  • 20. Ineffectiveness of zinc gluconate nasal spray and zinc orotate lozenges in common-cold treatment: a double-blind, placebo-controlled clinical trial.
    Eby GA, Halcomb WW.
    Altern Ther Health Med; 2006 Dec 01; 12(1):34-8. PubMed ID: 16454145
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.